Description
In recent years, the sirolimus market is anticipated to grow rapidly during the forecast period. Data Bridge Market Research analyses that the sirolimus market was valued at USD 221.0 million in 2021 and is expected to reach USD 316.70 million by 2029, registering a CAGR of 4.60% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. Data Bridge Market Research analyses that the sirolimus market was valued at USD 221.0 million in 2021 and is expected to reach USD 316.70 million by 2029, registering a CAGR of 4.60% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Analysis and Size
As per the World Health Organization (WHO), around 100,800 solid organ transplants are conducted worldwide each year, with 69,400 kidney transplants, 20,200 liver transplants, 5,400 heart transplants, 3,400 lung transplants, and 2,400 pancreas transplants being the most common. The increasing transplantation rate and the emergence of lifestyle-related diseases are the major factors leading to the high demand of sirolimus in the market.
Market Definition
Sirolimus, commonly known as rapamycin, is a macrolide molecule that is a strong immunosuppressant with antifungal and anticancer activities. It works by suppressing your immune system and assisting your body in accepting the new organ, so reducing organ rejection following transplant. Sirolimus is also used to coat coronary stents, as well as to treat lymphangioleiomyomatosis (lung disease) and to prevent organ transplant rejection in patients having renal transplants.
Scope and Market Segmentation
Segments Covered:
· Strength (0.5mg, 1mg, 2mg, 1mg/mL), Application (Organ Transplant Rejection, Sirolimus Catheter Device, Sirolimus Coated Balloons, Others), Drug Class (MTOR Inhibitors, Selective Immunosuppressants), Dosage (Injection, Tablet, Others), Route of Administration (Oral, Intravenous, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)
Countries Covered:
· U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players Covered:
· Accord Healthcare (US), Apotex Inc. (Canada), Amneal Pharmaceuticals LLC. (US), Pfizer Inc. (US), Zydus Cadila (India), Dr. Reddy's Laboratories Ltd. (India), Torrent Pharmaceuticals Ltd. (India), Biocon (India), Concept Medical (US), Intas Pharmaceuticals Ltd (India), Concord Biotech (India), Livzon (China), Actiza Pharmaceutical Private Limited (India), Tiefenbacher API + Ingredients GmbH & Co. KG (Germany), Delphis Pharmaceutical (India)
Market Opportunities:
- Increase in the number of emerging markets
- Increase in the number of research and development activities
- Rising investment for the development of advanced technologies
- Surging drug approvals and launches
Major TOC of the Nephrology and Urology Devices Market Report
Chapter One:
· MARKET SEGEMENTATION
· EXECUTIVE SUMMARY
· PREMIUM INSIGHTS
· MARKET OVERVIEW
Get TOC of the Report: https://www.databridgemarketresearch.com/toc/?dbmr= -sirolimus-market
Sirolimus Market Scope
The sirolimus market is segmented on the basis of strength, application, dosage, drug class, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Strength
· 0.5mg
· 1mg
· 2mg
· 1mg/mL
· Application
· Organ Transplant Rejection
· Sirolimus Catheter Device
· Sirolimus Coated Balloons
· Others
Drug Class
· MTOR Inhibitors
· Selective Immunosuppressants
Dosage
· Injection
· Tablet
· Others
Route of Administration
· Oral
· Intravenous
· Others
End-Users
· Hospitals
· Specialty Clinics
· Homecare
· Others
Distribution Channel
· Hospital Pharmacy
· Retail Pharmacy
· Online Pharmacy
· Others
Access Full Report:- https://www.databridgemarketresearch.com/reports/ -sirolimus-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Browse Related Reports@
